A new agreement between GlaxoSmithKline (GSK) and VentureWise—part of the MedicineWise Group—will see an independent educational program delivered to GPs on the topic of chronic obstructive pulmonary ...
GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback